Literature DB >> 4347708

Actions of the selective inhibitor of cholinesterase tetramonoisopropyl pyrophosphortetramide on the rat phrenic nerve-diaphragm preparation.

P F Heffron.   

Abstract

1. Tetramonoisopropyl pyrophosphortetramide (iso-OMPA) added for 15 min to the rat isolated phrenic nerve-diaphragm in a concentration of 30 muM, produced a complete selective and stable inhibition of cholinesterase. A concentration of 3 muM produced near complete inhibition of cholinesterase, and a concentration of 300 muM also inhibited acetylcholinesterase marginally.2. Inhibition of cholinesterase was associated with a sustained increase in the neuromuscular blocking action of exogenous butyrylcholine but not of exogenous acetylcholine. Iso-OMPA, 300 muM, in addition caused transient increases in the sensitivity of the rat diaphragm to exogenous acetylcholine and butyrylcholine. In the same concentration, it had a curare-like action on the frog rectus abdominis muscle preparation.3. Iso-OMPA, 30 muM, caused reversible increases in the amplitude of the twitch response and tetanic responses, which were of a similar magnitude in the indirectly stimulated preparation and the directly stimulated curarized preparation. Caffeine had a similar effect on the twitch response and its effectiveness was increased by iso-OMPA, and vice-versa. Amongst anticholinesterases, octamethyl pyrophosphortetramide and tetraethylpyrophosphate also enhanced the amplitude of the tetanic response, but paraoxon, dyflos, and mipafox did not.4. It is concluded that iso-OMPA, in concentrations (3 and 30 muM) which in 15 min give near maximal or maximal selective inhibition of cholinesterase, has no effect on the transmission of nerve impulses at the neuromuscular junction, but enhances reversibly the amplitude of the contractile response to stimulation by a direct action upon the muscle fibre, which involves a mechanism related to but not identical with that by which caffeine potentiates twitch tension. In higher concentrations, iso-OMPA has a curare-like action at the neuromuscular junction.

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4347708      PMCID: PMC1666370          DOI: 10.1111/j.1476-5381.1972.tb06896.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  10 in total

1.  Return of cholinesterase activity in the rat after inhibition by organophosphorus compounds. 2. A comparative study of true and pseudo cholinesterase.

Authors:  A N DAVISON
Journal:  Biochem J       Date:  1955-06       Impact factor: 3.857

2.  The differentiation of true and pseudo cholinesterase by organophosphorus compounds.

Authors:  W N ALDRIDGE
Journal:  Biochem J       Date:  1953-01       Impact factor: 3.857

3.  Two selective inhibitors of cholinesterase.

Authors:  L AUSTIN; W K BERRY
Journal:  Biochem J       Date:  1953-07       Impact factor: 3.857

4.  On the histochemistry of the myoneural junction.

Authors:  F A DENZ
Journal:  Br J Exp Pathol       Date:  1953-06

5.  The elimination of enzymatic diffusion artifacts in the histochemical localization of cholinesterases and a survey of their cellular distributions.

Authors:  G B KOELLE
Journal:  J Pharmacol Exp Ther       Date:  1951-10       Impact factor: 4.030

6.  The histochemical differentiation of types of cholinesterases and their localizations in tissues of the cat.

Authors:  G B KOELLE
Journal:  J Pharmacol Exp Ther       Date:  1950-10       Impact factor: 4.030

7.  Inhibition of cyclic nucleotide phosphodiesterase by adenosine 5'triphosphate and inorganic pyrophosphate.

Authors:  W Y Cheung
Journal:  Biochem Biophys Res Commun       Date:  1966-04-19       Impact factor: 3.575

8.  Choline ester hydrolases in diaphragm muscle.

Authors:  W K Berry; J P Rutland
Journal:  Biochem Pharmacol       Date:  1971-03       Impact factor: 5.858

9.  The action of caffeine on the activation of the contractile mechanism in straited muscle fibres.

Authors:  H C Lüttgau; H Oetliker
Journal:  J Physiol       Date:  1968-01       Impact factor: 5.182

10.  Adenosine 3',5'-phosphate in biological materials. I. Purification and properties of cyclic 3',5'-nucleotide phosphodiesterase and use of this enzyme to characterize adenosine 3',5'-phosphate in human urine.

Authors:  R W BUTCHER; E W SUTHERLAND
Journal:  J Biol Chem       Date:  1962-04       Impact factor: 5.157

  10 in total
  4 in total

Review 1.  Cocaine hydrolase gene therapy for cocaine abuse.

Authors:  Stephen Brimijoin; Yang Gao
Journal:  Future Med Chem       Date:  2012-02       Impact factor: 3.808

Review 2.  Interception of cocaine by enzyme or antibody delivered with viral gene transfer: a novel strategy for preventing relapse in recovering drug users.

Authors:  Stephen Brimijoin
Journal:  CNS Neurol Disord Drug Targets       Date:  2011-12       Impact factor: 4.388

3.  Mechanisms of the inhibition by neostigmine of tetanic contraction in the mouse diaphragm.

Authors:  C C Chang; S J Hong; J L Ko
Journal:  Br J Pharmacol       Date:  1986-04       Impact factor: 8.739

4.  Relationship between inhibition of acetylcholinesterase and response of the rat phrenic nerve-diaphragm preparation to indirect stimulation at higher frequencies.

Authors:  P F Heffron; F Hobbiger
Journal:  Br J Pharmacol       Date:  1979-06       Impact factor: 8.739

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.